RecallRadar
FDA · DrugsClass I

Baxter Healthcare Corporation drug recall: Cefazolin in Dextrose

Key facts

Agency
U.S. Food and Drug Administration (FDA)
Program
Drugs
Classification
Class I
Status
Ongoing
Event ID
99463
Recall initiated
Jul 24, 2026
Classified by FDA
Aug 21, 2026
Posted in Enforcement Report
Aug 19, 2026
Recalling firm
Baxter Healthcare Corporation
Firm location
Deerfield, IL, United States
Initiated by
Voluntary: Firm initiated
Firm notified customers by
Letter
Products in this event
1

What to do

Compare the product, lot or serial numbers below with what you have. If you use a prescription drug or medical device in this recall, talk to your pharmacist or health care provider before you stop using it, and follow the firm's instructions.

View the official FDA record ↗

Reason for recall

Presence of Particulate Matter

What the classification means

  • Class I: FDA's most serious category: there is a reasonable probability that using or being exposed to the product will cause serious health problems or death.

About this recall

The firm started this recall on Jul 24, 2026. FDA classified it 28 days later, on Aug 21, 2026. Distribution reported by FDA: US Nationwide. Baxter Healthcare Corporation has 279 recalls in our records.

Recalled products (1)

  • D-0787-2026 Class I Ongoing

    Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.

    Codes / lots: Lot # LD175708, Exp Date: 14-Feb-2027.

    Quantity: 19,032 bags

Source and freshness

Source
U.S. Food and Drug Administration (FDA) Enforcement Report, via the openFDA drug enforcement dataset
Official notice
FDA Enforcement Report, event 99463
Raw record
openFDA API (JSON)
Dataset last updated by FDA
Nov 3, 2026
Imported by RecallRadar
Nov 4, 2026

Enforcement Report entries describe recalls FDA has classified. They are not always the same as a company press release. If something here differs from FDA's record, FDA's record is correct — please tell us.

More recalls from this firm